Verona Pharma plc (VRNA) Misses Q4 EPS by 3c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist